Old Web
English
Sign In
Acemap
>
authorDetail
>
Takafumi Nishida
Takafumi Nishida
National Institutes of Health
Lecithin—cholesterol acyltransferase
Endocrinology
Internal medicine
Medicine
Drug-induced intrahepatic cholestasis
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
LCAT protects against Lipoprotein‐X formation in a murine model of drug‐induced intrahepatic cholestasis
2020
Pharmacology Research & Perspectives
Marcelo Amar
Lita A. Freeman
Takafumi Nishida
Maureen Sampson
Milton Pryor
Boris Vaisman
Edward B. Neufeld
Sotirios K. Karathanasis
Alan T. Remaley
Show All
Source
Cite
Save
Citations (5)
Development of a novel fluorescent activity assay for lecithin:cholesterol acyltransferase:
2018
Annals of Clinical Biochemistry
Toshihiro Sakurai
Akiko Sakurai
Boris Vaisman
Takafumi Nishida
Edward B. Neufeld
Stephen J. Demosky
Maureen Sampson
Robert D. Shamburek
Lita Freeman
Alan T. Remaley
Show All
Source
Cite
Save
Citations (6)
LCAT Overexpression Protects Against the Formation of LpX in a Murine Model of Drug Induced Intrahepatic Cholestasis
2018
Atherosclerosis Supplements
Marcelo Amar
Lita Freeman
Takafumi Nishida
Maureen Sampson
Milton Pryor
Alan T. Remaley
Show All
Source
Cite
Save
Citations (0)
1